Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2022

View Archived Issues

[68Ga]DOTA-ECL1i PET imaging in pancreatic cancer metastasis

KLF5 as novel therapeutic target to reduce tumorigenic GBM phenotype

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

Carbon Biosciences raises series A financing to advance cystic fibrosis program toward clinic

COR-803 reduces SARS-CoV-2 viral load in vivo after oral treatment

FOXI3 gene tied to craniofacial microsomia

NLRP11 identified as an essential component of the NLRP3 inflammasome in human macrophages

Study rekindles hope for exercise pill -- or at least, molecular exercise science

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...